Email Updates

Search form

You are here

Webinar & Meeting Reports

  • April 7, 2014

    This was the third webinar in AVAC's Research & Reality series, a year-long dialogue about prevention research and advocacy. The call provided a forum to learn about and discuss recent data and ongoing research on long-acting ARV injectables.

  • April 3, 2014

    The Los Angeles County PrEP Workgroup and AVAC’s PxROAR program presented the webinar The Doc is In: Prescribing, Managing and Billing for PrEP (pre-exposure prophylaxis) for HIV PreventionThis webinar aimed to address some of the key issues around PrEP prescribing, such as concerns around drug resistance, cost and reimbursement, risk assessment and side effects, among others.

  • March 10, 2014

    In this call we learned about and discussed proposed research to directly evaluate how different family planning methods might impact HIV risk.

  • March 3, 2014 to March 6, 2014

    The Conference on Retroviruses and Opportunistic Infections (CROI) is a scientifically focused meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS and its complications.

  • February 26, 2014

    This webinar kicked off our year-long dialogue about prevention research and advocacy, Research & Reality. We’ve designed the series to provide information and debate about key topics. Some of these are clear priorities, while others will undoubtedly emerge as data and country-level progress take us in new directions.

  • December 10, 2013

    Hosted jointly by NAM and AVAC, the last webinar for 2013 in our series addressed a range of topics in HIV prevention research, including the development of the EATG/NAM community consensus statement on treatment as prevention, a set of principles intended to guide policy on access to antiretroviral therapy for prevention purposes for people with HIV, to be launched in January.

  • December 9, 2013

    The final webinar of the Fall series discussed what is known from social and behavioral science and community experience about the definitions and perceptions of HIV risk among women that are relevant to their potential PrEP use.

  • November 3, 2013 to November 5, 2013

    This inaugural translational medicine conference: What Will it Take to Achieve an AIDS-Free World?, which will bring the audiences and editors of The Lancet and Cell together to bridge the gap between clinicians and researchers focused on understanding, managing, preventing and curing HIV/AIDS.

  • October 28, 2013

    The second in a series of webinars by the US Women and PrEP Working Group discussed the possibilities and challenges associated with serodiscordant couples using PrEP to help them achieve pregnancy safely.

  • October 7, 2013

    AIDS Vaccine 2013 took place from October 7–10 in Barcelona, Spain. AIDS Vaccine is the largest global scientific conference focused exclusively on AIDS vaccine research. Hosted annually by the Global HIV Vaccine Enterprise and local partners, AIDS Vaccine brings together the best and brightest scientific minds to exchange the latest research findings, explore new ideas, educate future leaders and engage a diverse community to help further research to develop a safe and effective HIV vaccine.